- Home
- » Tags
- » Nafadotride
Top View
- Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals
- Reevaluation of the Anhedonia Hypothesis of Dopamine Blocking
- MCLELLAND Angela Estelle
- Dopamine Receptors
- Dopaminergic Modulation of Risk-Based Decision Making
- Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease
- Synthesis and Evaluation of Tetrahydroprotoberberines As Dopamine Receptor Ligands
- FUNCTIONAL INTERACTIONS of Dl and D3 DOPAMINE RECEPTORS: GENERATION and BEHAVIOURAL ASSESSMENT of MICE LACKING BOTH RECEPTORS
- Selective Inhibition of Cocaine
- Dopamine D1 and D3 Receptor Polypharmacology in Cocaine Reward and Cocaine Seeking
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Cat# Name Description
- L-Nafadotride, GR 218231 and GR 103691: D3 Dopamine Receptor Antagonists
- Behavioral and Neuropharmacological Characterization of Nicotine As a Conditional Stimulus
- Acs.Jmedchem.8B00836 Aminergic Gpcrligand Interactions
- Opportunities and Challenges of Psychiatric Drug Discovery: Roles for Scientists in Academic, Industry, and Government Settings
- Known Bioactive Library: Tocriscreen Mini Library 2
- Catalog Update01 - International Update 31/01/2013 08:18 Page 1
- United States Patent (10) Patent No.: US 8,980,252 B2 Fallon Et Al
- Increased Levels of Proneurotensin/ Neuromedin N Mrna in Rat
- (12) Patent Application Publication (10) Pub. No.: US 2014/0038949 A1 Schultz Et Al
- Drug Repurposing to Treat Glucocorticoid Resistance in Asthma Alberta L
- Dopamine D1-Like, D2 and D3 Receptor Subtypes in Catalepsy Sensitization and Conditioning in Rats: Implications for Motor Function, Motivation and Learning
- Dopamine Receptors
- Dopamine Receptors and the Kidney: an Overview of Health- and Pharmacological-Targeted Implications
- Behavioral and Neuropharmacological Characterization of Nicotine As a Conditional Stimulus
- Beth Levant, Ph.D., M.P.A
- Effects of the Selective Dopamine D3 Receptor Antagonist, Nafadotride, on the Development of Behavioral Sensitization to Cocaine
- (12) United States Patent (10) Patent No.: US 9,592.288 B2 Schultz Et Al
- Besson Et Al., 2010
- NIDA - Director's Report - September 2005
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- (12) United States Patent (10) Patent No.: US 8,232,265 B2 Rogers Et Al
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- Parkinson's Disease Quality Measurement Set Update
- G Protein-Coupled Receptors
- Qt8746b5s5 Nosplash 24B28b2
- Yawning.Txt 24/10/09 20:55
- Neurochemical and Neuroanatomical Basis of Reversal
- 1111111111111111111Imnumu
- Induction of Dopamine D3 Receptor Expression As a Mechanism
- Targeting the Dopaminergic System in Autoimmunity
- Dopamine D2/D3 Receptor Agonist Quinpirole Impairs Spatial Reversal Learning in Rats: Investigation of D3 Receptor Involvement in Persistent Behavior
- Toxoplasma Gondii, Suicidal Behavior, and Intermediate Phenotypes for Suicidal Behavior
- Selegilin Exerts Antidepressant-Like Effects During the Forced Swim Test in Adrenocorticotropic Hormone–Treated Rats
- The Medicinal Chemistry of 2-Aminotetralin-Derived Benzamides
- Modulation of High Impulsivity and Attentional Performance in Rats by Selective Direct and Indirect Dopaminergic and Noradrenergic Receptor Agonists
- Veyres N, Hamadjida A, Huot P. Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey
- In Vivo Occupancy of D2 Dopamine Receptors by N Afadotride Beth Levant, Ph.D., and Nichole R
- Review Dopamine, Serotonin and Impulsivity
- Protein-Based Virtual Screening of Chemical Databases. II. Are